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ABSTRACT  21 
Actinobacillus pleuropneumoniae is a Gram-negative bacterium belonging to the Pasteurellaceae 22 
family and the causative agent of porcine pleuropneumonia, a highly contagious lung disease 23 
causing important economic losses. Surface polysaccharides including lipopolysaccharides (LPS) 24 
and capsular polysaccharides (CPS) are implicated in the adhesion and virulence of A. 25 
pleuropneumoniae, but their role in biofilm formation is still unclear. In this study, we 26 
investigated the requirement of these surface polysaccharides in biofilm formation by A. 27 
pleuropneumoniae serotype 1. Well characterized mutants were used: an O-antigen LPS mutant, 28 
a truncated core-LPS mutant with an intact O-antigen, a capsule mutant and a poly-N-29 
acetylglucosamine (PGA) mutant. We compared the amount of biofilm produced by the parental 30 
strain and the isogenic mutants using static and dynamic systems. Compared to the parental or 31 
other strains, the biofilm of the O-antigen and the PGA mutants was dramatically reduced and it 32 
had less cell-associated PGA. Real-time PCR analyses revealed a significant reduction in the level 33 
of pgaA, cpxR and cpxA mRNA in the biofilm cells of the O-antigen mutant compared to the 34 
parental strain. Specific binding between PGA and LPS was consistently detected by surface 35 
plasmon resonance but the lack of O-antigen did not abolish these interactions. In conclusion, the 36 
absence of the O-antigen reduces the ability of A. pleuropneumoniae to form a biofilm and this is 37 
associated with a reduction in the expression and the production of PGA.  38 
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INTRODUCTION 39 
     Actinobacillus pleuropneumoniae is a Gram-negative bacterium belonging to the 40 
Pasteurellaceae family and is the causative agent of porcine pleuropneumonia, a disease causing 41 
important economic losses to the swine industry worldwide (1). Several virulence factors of A. 42 
pleuropneumoniae have been identified. These factors include the Apx toxins, iron uptake 43 
systems and surface polysaccharides. These polysaccharides are divided in three categories: the 44 
lipopolysaccharides (LPS), the capsular polysaccharides (CPS), and the poly-N-acetyl-D-45 
glucosamine polymer (PGA) present in the biofilm matrix (2, 3, 4).  46 
     LPS are large biomolecules composed of three well defined regions: (i) lipid A, anchored in 47 
the outer membrane; (ii) the core oligosaccharide; (iii) the O-antigen, a polysaccharide consisting 48 
of repeating units. Altman and co-workers described the structure of A. pleuropneumoniae 49 
serotype 1 O-antigen as branched tetrasaccharide repeating units composed of two L-50 
rhamnopyranosyl, one D-glycopyranosyl, and one 2-acetamido-2-deoxy-D-glucose residues (5). 51 
The LPS inner core oligosaccharide is relatively conserved among A. pleuropneumoniae 52 
serotypes 1, 2, 5a and 5b and is composed of 2-keto-3-deoxyoctulosonic acid and heptose 53 
whereas the outer core oligosaccharide is variable among serotypes and is generally made of 54 
variable number of branching hexoses (6). The A. pleuropneumoniae LPS has been identified as 55 
an adhesin and the polysaccharide part of the LPS, but not the lipid A, is implicated in the 56 
adhesion to porcine respiratory tract cells and mucus (7, 8). Furthermore, an intact LPS core is 57 
essential for adhesion and virulence (9, 10).  58 
     Another major surface component of A. pleuropneumoniae serotype 1 is the capsular 59 
polysaccharide, composed of a repeating disaccharide unit of 2-acetamido-2-deoxy-D-glucose 60 
and D-galactose (11). CPS is encoded by the cpsABCD and cpxDCBA genes which include an 61 
ABC transport system responsible for the export of the CPS (12) and is considered as crucial 62 
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virulence factor of A. pleuropneumoniae (13, 14). A capsule mutant had enhanced adhesion to 63 
porcine epithelial cells (13, 15). Thus, it is thought that the CPS is not involved in adherence and 64 
rather appears to mask adhesins required for attachment (13, 16).  65 
    Recent literature indicates the presence of a third category of surface polysaccharides in A. 66 
pleuropneumoniae; an exopolysaccharide (EPS) that covers and holds bacteria together, 67 
composed of PGA (17, 18). In A. pleuropneumoniae, this polymeric matrix has been shown to be 68 
involved in the formation of a robust biofilm in a very short period of time (4). Biofilms are 69 
sessile communities of microorganisms attached to a biotic or abiotic surface and enclosed in a 70 
self-produced extracellular polymer matrix (19, 20). These are more frequently associated with 71 
chronic diseases due particularly to an increased resistance to both conventional biocides and host 72 
immune system (20, 21, 22). In this context, we have shown that A. pleuropneumoniae biofilm 73 
cells were 100 to 30,000 times more tolerant to antimicrobials compared to their planktonic 74 
counterparts (23).  75 
     The position of surface polysaccharides at the bacterium/surface interface is crucial for 76 
adhesion (24) and, consequently, likely plays a key role in biofilm formation by facilitating 77 
attachment, microcolony formation, and/or subsequent maturation of the biofilm. Indeed, several 78 
genetic determinants of A. pleuropneumoniae have also been associated with biofilm formation in 79 
microtiter plates or drip flow reactors, and genes associated with LPS, CPS and PGA biosynthesis 80 
have been identified in transposon mutants and transcriptomic analysis (25-27).  In this study, we 81 
investigated the role of surface polysaccharides in biofilm formation of A. pleuropneumoniae. We 82 
specifically used well-characterized LPS, CPS and PGA isogenic mutants of A. 83 
pleuropneumoniae serotype 1 strain 4074 (9, 13, 15, 25) and investigated the influence of these 84 
structural mutations on functional biofilm formation under static condition or low shear force 85 
condition.  86 
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MATERIALS AND METHODS 87 
 88 
     Bacterial strains and growth conditions. A. pleuropneumoniae strains were grown on Brain 89 
Heart Infusion agar or broth (BHI; Oxoid Ltd, Basingstoke, Hampshire, UK) supplemented with 90 
15 µg/mL β-NAD (BHI-NAD) at 37°C with 5% CO2. All bacterial strains used in the present 91 
study are listed in Table 1. 92 
 93 
     Microtiter plate biofilm assay. We used a microtiter plate biofilm assay as described 94 
previously (4). Briefly, the wells of a 96-well microtiter plate (Costar 3599, Corning, NY, USA) 95 
were filled in triplicate with a dilution (1/100) of an overnight bacterial culture. Following an 96 
incubation of 4 h at 37°C with 5% CO2, the culture medium was removed by aspiration and the 97 
plate was washed once by immersing the plate in water. The wells were then filled with 100 µL of 98 
crystal violet (0.1% w/v) and the plate was incubated for 2 min at room temperature. After 99 
removal of the crystal violet solution, the plate was washed and dried in a 37°C incubator for 30 100 
min and 100 µL of ethanol (70% v/v) were added to the wells. Absorbance was measured at 590 101 
nm using a spectrophotometer (Powerwave, BioTek Instruments, Winooski, VT, USA). The 102 
surface attachment of bacteria to polystyrene after a short incubation time of 2 h was measured as 103 
described before (26). Images of the adherent bacteria were captured with a microscope (Leica, 104 
DMI 4000 B, Microsystems Inc., Richmond Hill, ON, Canada) using a DFC490 digital camera 105 
(Leica) and documented using the associated software version 2.4.0. These images were analyzed 106 
using ImageJ (National Institutes of Health, Bethesda, MD, USA) USA); reported is the average 107 
number of particles (bacterial cells) from three fields of view across two independent biological 108 
replicates. 109 
 110 
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     Drip flow biofilm reactor. A drip flow biofilm reactor (DFR 110-4 model, BioSurface 111 
Technologies Corporation Bozeman, MT, USA) was used to cultivate biofilms under continuous 112 
low shear force on a glass slide as described before (27) with some modification; the flow rate was 113 
set to 50 mL/h per channel. After 24h, the attached cells were scraped off the glass slide and 114 
resuspended in 1 mL of PBS. After centrifugation, the supernatant was discarded and pellets were 115 
dried using DNA 120 Speed Vac® (Thermo Scientific, Ottawa, ON, Canada). When possible, the 116 
dry weight of the biofilms was measured and the dried biofilms were kept for further analyses.  117 
 118 
     Confocal laser scanning microscopy (CLSM). Biofilms were grown in the microtiter plate 119 
biofilm assay as described above and stained with Wheat Germ Agglutinin (WGA)–Oregon Green 120 
488 (Invitrogen, Eugene, OR, USA), BOBO-3 (Invitrogen), FilmTracer™ SYPRO® Ruby Biofilm 121 
Matrix Stain (Invitrogen), FilmTracer LIVE⁄DEAD Biofilm Viability Kit (Invitrogen) or 122 
FilmTracer™ FM®1-43 (Invitrogen) as prescribed by the manufacturer. Based on the information 123 
provided by the manufacturer, WGA will binds to N-acetyl-D-glucosamine and N-124 
acetylneuraminic acid residues, BOBO-3 is a cell-impermeable extracellular DNA stain and 125 
SYPRO Ruby stain labels most classes of proteins. FilmTracer™ FM®1-43 is a green cell dye that 126 
stain bacterial membranes. The stained biofilms were visualized by confocal laser scanning 127 
microscopy (CLSM; FV1000 IX81; Olympus, Markham, ON, Canada) and images were acquired 128 
using the Fluoview software (Olympus).  Biomass analysis of the biofilms was carried using the z-129 
stack images obtained from areas selected randomly. The biomass and average thickness of 130 
biofilms were determined using Image Pro (Media Cybernetics, MD, USA) as described before 131 
(27). 132 
 133 
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     Enzymatic treatments. A biofilm dispersion assay was performed as described previously 134 
(28). Biofilms were grown in microtiter plates, and after the 4 h incubation, 50 μL of DNase I (500 135 
μg/mL in 150 mM NaCl, 1 mM CaCl2), 50 μL of dispersin B (100 μg/mL in PBS; Kane Biotech 136 
Inc., Winnipeg, MB, Canada), or 50 μL of proteinase K (500 μg/mL in 50 mM Tris-HCl pH 7.5, 1 137 
mM CaCl2) was added directly to the biofilms. Control wells were treated with 50 μL of the buffer 138 
without the enzyme. Wells treated with dispersin B were incubated for 5 min at 37°C, and those 139 
treated with proteinase K or DNase I were incubated for 1 h at 37°C. After the treatments, the 140 
biofilms were stained with violet crystal as described above.  141 
 142 
      Semi-quantitative detection of PGA. A. pleuropneumoniae strains were grown either in 6-143 
well plates (Costar® 3516) or in the drip flow reactor. Culture supernatants were collected, 144 
centrifuged to remove bacteria, and used for immunodetection of PGA. Biofilms were scraped off, 145 
resuspended in PBS, centrifuged and dried as described in the drip flow biofilm reactor section. 146 
The dried biofilms were resuspended in water to a concentration of 10 mg/mL, and were then 147 
treated with proteinase K (100 µg/mL) for 1 h at 37°C. The treated biofilm suspensions were 148 
serially diluted and these two-fold dilutions were transferred to a nitrocellulose membrane 149 
(Millipore, Billerica, MA, USA) using a 96-well dot blot vacuum manifold system (Bio-Rad, 150 
Hercules, CA, USA). The membrane was air dried and then blocked with 5% (w/v) skim milk in 151 
Tris-buffered saline with Tween (TTBS;  145 mM NaCl, 100 mM Tris/HCl pH 7.4 supplemented 152 
with 0.15% (v/v) Tween 20) for 1 h. The blocked membrane was incubated with a goat anti-poly-153 
N-acetyl glucosamine antibody (1:2500; kindly supplied by Dr. G. Pier, Harvard Medical School, 154 
Boston, USA) in TTBS containing 5% (w/v) skim milk for 1h followed by three washes with 155 
TTBS. The membrane was then incubated with a rabbit anti-goat horseradish peroxidase conjugate 156 
antibody (1:10000, Jackson ImmunoResearch Laboratories West Grove, PA, USA) in TTBS 157 
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containing 5% (w/v) skim milk for 30 min and then washed thrice with TTBS. The membrane was 158 
developed with the substrate TMB (Sigma-Aldrich). Water was added to wells as a negative 159 
control. The experiments were repeated three times. 160 
 161 
     Extraction and analysis of eDNA in biofilm matrix. A 1/100 dilution of an overnight culture 162 
of A. pleuropneumoniae strains was incubated in 6-well plates (Costar® 3516) for 4 h at 37°C 5% 163 
CO2. After this time medium was removed, biofilms were washed, gently scraped from the surface 164 
and resuspended in 1.5 mL of 0.9% NaCl. For each strain, biofilms from five wells were pooled to 165 
represent one sample. Biofilms were resuspended and treated with 20 µg/mL of dispersin B to 166 
promote the release of eDNA. Cells were then separated from the supernatant containing the 167 
eDNA fraction by centrifugation at 14,000 g for 2 min. Extracellular and intracellular DNA from 168 
the supernatant and cell pellet, respectively, were extracted using the phenol/chloroform method as 169 
described before (29, 30). DNA concentration and purity were determined with a NanoDrop 170 
spectrophotometer and ratio eDNA/iDNA was calculated. eDNA and iDNA were also visualized 171 
on agarose (0.8%) gels. 172 
 173 
      Quantitative real-time reverse-transcriptase (qRT)-PCR analysis. Parental and surface 174 
polysaccharide mutant strains were grown in 6-well plates (Costar® 3516) for 4 h. Planktonic and 175 
biofilm cells were collected separately using ice-cold methanol to prevent changes in transcript 176 
levels. RNA extraction and a two-step qRT-PCR were performed as described elsewhere (27). The 177 
primers used to amplify the pgaA, cpxR, cpxA, dspB and 16S rRNA genes are listed in Table 2. 178 
MaximaTM SYBR Green kit (Thermo Scientific Fermentas, Glen Burnie, MD, USA) was used for 179 
SYBR green labeling analysis (16-place Cepheid Smart Cycler® System). Triplicates of qRT-PCR 180 
mixtures (25 μL) containing 0.75 ng of cDNA for each experiment were prepared.  Relative 181 
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expression was normalized using the 16S rRNA gene as the endogenous control, and the results 182 
were analyzed by a threshold cycle (ΔΔCT) to calculate fold change in gene expression (31). Each 183 
sample was measured in duplicate, and the experiment in its entirety was repeated three times. 184 
 185 
     LPS extraction. LPS of parental strain 4074NalR and O-antigen mutant 44.1 were isolated 186 
from dried cell masses by the Darveau-Hancock method (32). Briefly, disrupted cells were treated 187 
with DNase, RNase, pronase and sodium dodecyl sulphate (SDS). Treated cells were subjected to 188 
MgCl2 precipitation and high-speed centrifugation. All samples were lyophilized and the LPS 189 
purity was evaluated on SDS-polyacrylamide gels and stained with silver (9).  190 
 191 
     Surface plasmon resonance (SPR). Binding between purified PGA (generously provided by 192 
Dr. Irina Sadovskaya, Université du Littoral-Côte d’Opale, Boulogne-sur-Mer, France) and LPS 193 
(both parental and O-antigen mutant 44.1) was examined using a BIACORE 3000 system (GE 194 
Healthcare Bio-Sciences AB, Upsala, Sweden).  All lyophilized stocks were resuspended to 1 195 
mg/mL in PBS. Experiments were performed on HPA sensor chips (Biacore) at 25°C using 196 
filtered (0.2 μm) and degassed running buffers: HBS-N (10 mM HEPES pH 7.4, 150 mM NaCl) 197 
and/or PBS-E (1 mM EDTA in 10 mM sodium phosphate dibasic, 1.8 mM potassium phosphate 198 
monobasic, 137 mM NaCl, 2.7 mM potassium chloride; EDTA is believed to favour the smallest 199 
1000 kDa form of LPS, as noted in Sigma product data sheet #L-2630).  All chemicals were 200 
reagent grade quality, including protein-grade n-octyl-b-D-glucopyranoside (10% (v/v) nOG 201 
stock (Affymetrix-Anatrace #0311, IL, USA), fatty acid-free bovine serum albumin (10 mg/mL 202 
BSA stock prepared in water; Sigma #A-8806. St-Louis, MO, USA), and glucocerebrosides (2 203 
mg/mL glucocerebrosides stock prepared in chloroform:methanol (2:1) solution; Matreya #1322, 204 
Pleasant Gap, PA, USA). Immobilized surfaces were prepared via hydrophobic adsorption to 205 
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HPA sensors as previously described (33).  Briefly, the flowcells were pre-washed (5 µL/min x 206 
25 µL x 2) with nOG (10% stock x 1/9 dilution in water = ~40 mM).  Active (e.g. 1 mg/mL PGA 207 
in PBS) and reference biomolecules (e.g. 0.7 mg/mL GLU in 70% ethanol; 1 mg/mL BSA in 208 
buffer) were injected at 5 µL/min until surface densities of ~1000 RU were obtained.  Surfaces 209 
were washed with NaOH (5 mM in buffer; 50 µL/min x 25 µL) before blocking with BSA (0.5 210 
mg/mL in buffer; 50 µL/min x 250 µL).  Surfaces were finally stabilized with NaCl (1 M in 211 
buffer; 50 µL /min x 25 µL x 3) before use.  For reversed “analyte-ligand” orientation, active (1 212 
mg/mL parental or O-antigen mutant LPS in PBS) and reference surfaces (e.g. 1 mg/mL PGA in 213 
PBS) were prepared in the similar fashion. 214 
     To screen for binding specificity, fixed concentrations of LPS (parental or O-antigen mutant), 215 
PGA, and/or BSA (negative control) were injected over reference and active surfaces in-tandem at 216 
10 – 25 µL/min (e.g. 1 min association + 1 min dissociation; multi-cycle mode using HBS-N or 217 
PBS-E running buffers).  Between sample injections, surfaces were regenerated at 50 µL/min 218 
using two 30-second pulses of solution I (1 M imidazole pH 9.5) and solution II (1 M guanidine 219 
pH 2.0), followed by routine washing procedures (i.e. 'EXTRACLEAN' and 'WASH' options).  To 220 
further examine the binding kinetics, parental/mutant LPS and PGA were titrated over sensor 221 
surfaces at 10 – 25 µL/min (e.g. 1 min association + 1 – 5 min dissociation; single-cycle mode 222 
using HBS-N or PBS-E running buffers); between titrations, surfaces were regenerated as noted 223 
above. The double-referenced data (34) presented is representative of duplicate injections acquired 224 
from three independent trials.  Due to the inherent sample heterogeneity with both PGA and LPS 225 
(i.e. each a mixture of highly variable MW species), the binding kinetics could not be fit to “1:1 226 
titration” model in the BIAevaluation software. 227 
 228 
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     Statistical analysis. Data were analyzed with GraphPad Prism, version 5.0, software 229 
(GraphPad Inc., San Diego, CA) using one-way analysis of variance (ANOVA) followed by the 230 
Dunnett’s multiple comparison test. A P-value of 0.05 or less was considered to be statistically 231 
significance. 232 
 233 
RESULTS 234 
 235 
     Absence of O-antigen and PGA reduce biofilm formation. Biofilm formation by the parental 236 
strain and surface polysaccharide mutants was assessed using static and low shear force models. In 237 
a static, 96-well microtiter plate assay, the biofilm formed by the pgaC mutant was, as expected, 238 
barely detected compared to the parental strain (Fig.1A). The amount of biofilm formed by the O-239 
antigen mutant 44.1 was significantly reduced (P<0.05) compared to the parental strain 4074NalR, 240 
the LPS-core mutant CG3 and the capsule mutant 33.2 (Fig.1A).  Our results indicate that absence 241 
of either PGA or O-antigen negatively impacts biofilm formation by A. pleuropneumoniae. 242 
     To further analyze the LPS, CPS and PGA mutants, we examined biofilm formation in the drip 243 
flow reactor, a continuous-flow model with an air-liquid interface and low shear force considered 244 
to be more representative of the lung environment (35). While the O-antigen mutant barely formed 245 
detectable thin biofilms, the parental strain 4074NalR, the LPS-core mutant CG3, and the capsule 246 
mutant 33.2 formed similar amounts of thick, rough biofilms (Fig. 1B). The pgaC mutant was 247 
unable to form a biofilm in this system. These results cross-validated that absence of the O-antigen 248 
or PGA reduces the ability of A. pleuropneumoniae serotype 1 to form a mature biofilm, whereas 249 
truncation of the core oligosaccharide with an intact O-antigen or absence of the capsule 250 
polysaccharide do not affect biofilm formation under static (i.e. 96-well microtiter plate assay) and 251 
low shear force (i.e. drip flow reactor) conditions.  252 
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 253 
     Absence of O-antigen and PGA does not affect the initial attachment of A. 254 
pleuropneumoniae to an abiotic surface. Given that the initial attachment of bacteria to a surface 255 
is a critical step for biofilm formation, we examined the attachment of A. pleuropneumoniae to the 256 
plastic surface of 96-well plates (Fig. S1). Image analysis showed that the overall number of 257 
attached cells for both O-antigen mutant 44.1 (Fig. S1 Panel B) and LPS-core mutant CG3 (Fig. 258 
S1 Panel C) appeared to be similar to the parental strain (Fig. S1 Panel A). The pgaC mutant (Fig. 259 
S1 Panel E) had fewer cells; however, this difference was not significant (p >0.05). In contrast, 260 
more attached cells were detected for the capsule mutant 33.2 (Fig. S1 Panel D). It is unlikely that 261 
the initial rate of A. pleuropneumoniae attachment accounts for the inability of both mutants, O-262 
antigen and PGA, to form a biofilm.  263 
 264 
     Biofilm morphology and composition. The biofilm architecture was visualized by CLSM 265 
using a WGA fluorescent probe specifically targeted to PGA, the major component of the biofilm 266 
matrix of A. pleuropneumoniae. While the O-antigen mutant 44.1 formed only small, patchy 267 
microcolonies after 4 h of incubation in microtiter plates (Fig. 2B), the LPS-core mutant CG3 (Fig. 268 
2C) and the capsule mutant 33.2 (Fig. 2D) formed biofilms similar to the parental strain (Fig. 2A). 269 
As quantified from the confocal images, the biofilm biomass of the O-antigen mutant 44.1 was 270 
significantly reduced (i.e. under 0.1 µm3/µm2) compared to the parental strain, LPS-core mutant 271 
CG3, and capsule mutant 33.2 (i.e. 4.50±0.84, 5.26±1.1, and 4.44±0.89 µm3/µm2, respectively). 272 
Since the pgaC mutant is deficient in PGA production, the staining with WGA, which recognizes 273 
N-acetyl-D-glucosamine and N-acetylneuraminic acid residues, was negative (data not shown). 274 
Therefore, we used FilmTracer™ FM®1-43, a fluorescent probe that targeted bacterial 275 
membranes, to visualize the biofilm of the pgaC mutant. As observed by CLSM, the biofilm of 276 
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pgaC mutant was characterized by isolated clusters (Fig. 3). Similar to the O-antigen mutant, the 277 
pgaC mutant was deficient in biofilm formation. Therefore, the CLSM data was consistent with 278 
the biofilm results obtained from the microtiter plate (violet crystal staining) and drip-flow (dry 279 
weight measurements) assays. In addition to PGA, the biofilm of A. pleuropneumoniae parental 280 
strain was also stained with cell impermeable dyes to determine the overall matrix composition. 281 
Significant amounts of extracellular DNA (eDNA, stained with BOBO-3) and proteins (stained 282 
with SYPRO Ruby) were detected within the parental biofilm (data not shown).  283 
     To further examine the contribution of PGA, proteins, and eDNA to the matrix architecture, 284 
preformed biofilms were treated with dispersin B, proteinase K, and DNase I. Dispersin B, a 285 
biofilm-releasing glycoside hydrolase that degrades PGA, was able to significantly disperse the 286 
preformed biofilms (p<0.05) of the parental strain, the LPS-core mutant, and capsule mutant (Fig. 287 
4). Given that the O-antigen and pgaC mutants produce biofilms barely above the limit of 288 
detection of the assay, dispersal of their biofilms by enzymatic digestion was difficult to detect 289 
and, thus, not observable (data not shown). Indicative that eDNA and proteins do not play a major 290 
role in the architecture of static A. pleuropneumoniae biofilms, digestions with proteinase K, a 291 
broad-spectrum serine protease, and DNase I, a site-specific nuclease, were not able to disperse the 292 
mature biofilms. The low amount of eDNA in the biofilm matrices (ranging from 26 ng/µL to 45 293 
ng/µL; approximately one tenth of the intracellular DNA content, based upon our equalized 294 
parental, CG3, and 33.2 biofilm extractions) suggests that eDNA does not contribute to the 295 
architecture of A. pleuropneumoniae biofilms.   296 
 297 
     Specific binding between PGA and LPS. Label-free, real-time SPR was utilized to test if 298 
PGA specifically interacts with LPS. With PGA (net positive at pH 7) immobilized to HPA 299 
sensor surfaces (Fig. 5A), fixed concentrations of LPS from the parental strain and the O-antigen 300 
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mutant 44.1 (both net negative in HBS-N running buffer) generated significant binding responses; 301 
in contrast, there was little or no signal change when BSA, a negatively charged protein at pH 7 302 
(36), was injected as a non-binding control. Moreover, glucocerebrosides (net neutral) were 303 
chosen as the corresponding reference surfaces in the Figure 5A assays to ensure that there was 304 
minimal non-specific binding of parental/mutant LPS to the sensors in the absence of PGA. Due 305 
to the inherent heterogeneity of the parental/mutant LPS and PGA samples tested (i.e. form 306 
aggregates of varying size), the observed binding profiles deviated from simple 1:1 kinetics as 307 
anticipated (e.g. the heterogeneous O-antigen binding profile in Fig. 5A). Regardless, fixed 308 
concentrations of PGA (in PBS-E running buffer) once again generated significant binding 309 
responses against LPS from both the parental strain and the O-antigen mutant 44.1 when the 310 
“analyte-ligand” orientation was reversed (Fig. 5B). Using the optimized assay orientation (i.e. 311 
the ease of regeneration of sensor surfaces when LPS was injected over immobilized PGA), 312 
additional kinetic titrations (Fig. 5C) demonstrated that the binding of both the parental strain and 313 
O-antigen mutant LPS to PGA was dose-dependent. Although equimolar concentrations of 314 
parental and mutant 44.1 LPS were anticipated to yield similar SPR signal changes (i.e. similar 315 
MW) when interacting with PGA, differences in their intrinsic properties (e.g. exposed binding 316 
interfaces) likely account for fluctuations in the absolute binding responses (e.g. Fig. 5A and 5C, 317 
larger signal shift with mutant 44.1 LPS; Fig. 5B, larger signal shift with parental strain LPS).  318 
While the inherent heterogeneity of both PGA and LPS (i.e. each a mixture of highly variable 319 
MW species) did not allow us to assess overall binding affinities, specific, dose-dependent 320 
binding between PGA and LPS was consistently detected using multiple assay orientations, 321 
running buffers, and reference surfaces. A lack of interaction between LPS and PGA does not 322 
account for the inability of O-antigen mutant 44.1 to form mature biofilms. 323 
 324 
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     O-antigen mutant produces less PGA. Biofilms grown under both static and drip flow 325 
conditions were collected (normalized according to dry weight) and the relative amounts of 326 
associated PGA were semi-quantified by immunoblotting. In both cases, biofilms of the O-antigen 327 
mutant 44.1 had less PGA associated with its cells compared to similar amounts detected for the 328 
parental strain 4074NalR, the LPS-core mutant CG3, and the capsule mutant 33.2 (Fig. 6). Under 329 
static conditions, the amount of PGA in the biofilm supernatant was also measured to verify that 330 
the PGA produced was not released into the growth medium. As with the biofilm/cell-associated 331 
PGA results, less PGA was also detected in the O-antigen mutant supernatant (Fig. S2). Taken 332 
together, our data indicate that the O-antigen mutant 44.1 produced less PGA than the parental 333 
strain.  It should be noted that the barely detectable biofilm formed by the pgaC mutant did not 334 
allow us to perform immunoblotting with this mutant. 335 
 336 
     Analysis of pgaA, cpxR, cpxA and dspB expression by real-time RT-PCR. To verify the 337 
effect of the LPS and CPS biosynthetic gene mutations on PGA production, the expression of 338 
pgaA (one of the genes in the operon pgaABCD encoding for PGA production) was measured in 339 
mature biofilms. The expression of pgaA was down-regulated (p < 0.05) in the O-antigen mutant 340 
44.1 (Fig. 7A), whereas expression in the core oligosaccharide mutant CG3 and the acapsular 341 
mutant 33.2 was not significantly different compared to the parental strain 4074NalR.  Given that 342 
cpxR and cpxA (37-39) are differentially regulated in A. pleuropneumoniae biofilms (27), their 343 
expression was also measured.  Both genes were down-regulated (p < 0.05) in the O-antigen 344 
mutant 44.1, whereas no significant differences in expression were observed for the LPS core 345 
oligosaccharide mutant CG3 and the acapsular mutant 33.2 (Fig. 7B). The expression of dspB 346 
coding for the dispersin B enzyme was also measured. No difference in expression of the dspB 347 
gene was detected between the O-antigen mutant 44.1 and the parental strain (data not shown). 348 
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Once again, it should be noted that the barely detectable biofilm formed by the pgaC mutant did 349 
not allow us to perform qRT-PCR with this mutant. 350 
  351 
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DISCUSSION  352 
 353 
     Surface polysaccharides including LPS, CPS and PGA have been linked to biofilm formation in 354 
several bacterial species (17, 25, 40-51) thus investigating their unassessed role in the biofilm 355 
formation of A. pleuropneumoniae serotype 1 was the focus of our present study. LPS and CPS 356 
have been implicated in both adhesion and virulence of A. pleuropneumoniae, but their role in 357 
biofilm formation is still unclear.  For example, LPS and CPS can affect the adhesion of A. 358 
pleuropneumoniae to epithelial cells and mucus (9, 13, 15) and, as previously demonstrated by our 359 
laboratory, the core oligosaccharide of LPS is required for its adherence to porcine respiratory 360 
tract cells (9). To our knowledge, this is the first report that an O-antigen mutant of A. 361 
pleuropneumoniae serotype 1 is severely defective in biofilm formation in both static and low 362 
shear force models (Fig. 1). Confocal microscopy with PGA-specific staining confirmed that the 363 
O-antigen mutant biofilms were patchy, small microcolonies compared to the dense, thick parental 364 
strain biofilms (Fig. 2). These findings indicate that lack of the O-antigen significantly impairs 365 
biofilm formation of A. pleuropneumoniae serotype 1. At the same time, the adherence of the O-366 
antigen mutant 44.1 to an abiotic surface was not affected (Fig. S1) and, based upon our previous 367 
work, absence of the O-chains does not affect the overall surface hydrophobicity and charge of the 368 
O-antigen mutant 44.1 (15). Overall, the defective biofilm formation that we observed with the O-369 
antigen mutant of A. pleuropneumoniae serotype 1 is likely due to its inability to progress from 370 
microcolonies into a mature biofilm. Our findings are consistent with other bacterial species where 371 
a loss of O-antigen has profound effects. For example, biofilm formation and EPS accumulation of 372 
Xanthomonas oryzae pv. Oryzicola were affected by the loss of O-antigen (40). Li and co-workers 373 
observed that mutations in the wxacO and rfbC genes (involved in the biosynthesis of 374 
Xanthomonas citri ssp.citri O-antigen LPS) impaired biofilm formation on plastic surfaces and 375 
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host plant leaves (41). The formation of Stenotrophomonas maltophilia biofilms requires an intact 376 
LPS and a mutation in O-antigen biosynthesis affects EPS production and biofilm formation (42). 377 
Clifford and co-workers showed that O-antigen of Xylella fastidiosa is needed for biofilm 378 
maturation and surface attachment (50). Recently, it was demonstrated that mutations in the 379 
waaWVL operon, encoding for LPS biosynthesis genes, lead to a shorter LPS species and a 380 
decreased ability of adherent-invasive E. coli (AIEC) strain LF82 to form biofilms (51). On the 381 
other hand, Ciornei and co-workers have demonstrated that the ability of Pseudomonas aeruginosa 382 
to form a mature biofilm is dependent on a shorter form of LPS or a complete loss of O-antigen 383 
(52). Additionally, Coulon and co-workers found that the extracellular matrix of P. aeruginosa 384 
biofilms contains significant amounts of O-antigen polysaccharides (53).  385 
     The pgaC mutant, which lacks an integral membrane glycoside transferase enzyme (PgaC) 386 
catalyzing the polymerization of PGA from UDP-GlcNAc monomers, was also deficient in 387 
biofilm formation, like the O-antigen mutant. The biofilms produced by the pgaC and O-antigen 388 
mutants were barely detectable in vitro and were characterized by few dispatched colonies 389 
attached to the surface, however adherence to an abiotic surface was not affected for either mutant. 390 
Izano et al. previously showed that an A. pleuropneumoniae serotype 5 pgaC mutant was deficient 391 
in EPS, and this mutant failed to form biofilm in vitro (54). Our results indicate that both PGA and 392 
O-antigen are important for biofilm production by A. pleuropneumoniae serotype 1.  393 
     While other groups have shown that the LPS core oligosaccharide is essential for biofilm 394 
formation of E. coli, Klebsiella pneumoniae and S. maltophilia (42-44), our LPS-core mutant CG3 395 
was still able to produce biofilms similar to the parental A. pleuropneumoniae strain (Fig. 1). 396 
Other groups have also shown that capsule expression can affect the biofilm formation of 397 
pathogens such as Vibrio vulnificus (45) and Porphyromonas gingivalis (46). For example, capsule 398 
synthesis genes (wza and wzc for Klebsiella pneumoniae, and kpsM for E. coli) were recently 399 
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shown to negatively affect biofilm formation (47, 48). In contrast, our acapsular mutant 33.2 400 
produced a biofilm similar to the parental A. pleuropneumoniae strain despite the former 401 
exhibiting enhanced adherence. These results are consistent with a previous study demonstrating 402 
that acapsular mutant 33.2 adheres significantly more to piglet tracheal frozen sections than the 403 
parental strain (13), and also with a study by Karwacki and co-workers who showed that biofilms 404 
of an acapsular A. pleuropneumoniae serotype 5 mutant were not affected on 96-well polystyrene 405 
microtiter plates compared to the wild-type strain (49). 406 
      As the importance of surface polysaccharide in biofilm formation continues to be recognised in 407 
the literature, our data and the studies noted above reinforce the potential role of O-antigen and 408 
PGA, but not the core oligosaccharide and the capsule, in biofilm formation and maturation of A. 409 
pleuropneumonaie serotype 1. Treatment with dispersin B completely dispersed preformed 410 
biofilms thereby confirming that PGA is a key scaffolding component of the matrix (4, 26). Within 411 
the biofilms of P. aeruginosa and Staphylococcus aureus, eDNA is required for the attachment, 412 
aggregation, and stabilization of microcolonies and DNase treatment will remove the biofilms (55, 413 
56). While we detected eDNA within the biofilm matrix of our parental and mutant A. 414 
pleuropneumoniae strains, DNase I treatment did not disperse the pre-formed biofilms. Since 415 
proteinase K treatment also did not lead to a dispersion of the biofilms, our data indicates that 416 
PGA, eDNA, and proteins are all part of the matrix, but only PGA is critical for biofilm formation 417 
by A. pleuropneumoniae serotype 1. 418 
     It has been shown that LPS  mediates interactions with EPS. For example, binding has been 419 
observed between LPS and PGA from E. coli (43), and between LPS and cellulose, an EPS in the 420 
biofilm of Pseudomonas fluorescens (57).  Amini and co-workers showed that modified E. coli 421 
LPS (with less negatively charged phosphate groups) decreases its interaction with the positively 422 
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charged expolysaccharide PGA (43).  The findings by Amini highlight the importance of 423 
electrostatic interactions between LPS and EPS for biofilm development, strength, and integrity. 424 
     While significantly less is known about interactions between surface polysaccharides in A. 425 
pleuropneumoniae, the P. fluorescens and E.coli studies prompted us to hypothesize that PGA 426 
may perhaps interact directly with LPS in A. pleuropneumoniae. Using SPR, multiple assay 427 
designs (i.e. different coupling orientations, running buffers, and reference surfaces) consistently 428 
detected specific binding between the two surface polysaccharides (Fig. 5). In comparison to 429 
other LPS studies in the SPR literature, our assays were performed using stringent flow rates (i.e. 430 
25 µL/min, like that used by Bahl et al. (58)) and avoided complicating carrier proteins such as 431 
BSA, in the running buffer (59). Similar to the high-affinity interaction reported by Bahl et al. 432 
(58), that mapped specific LPS-binding hot spots on hemoglobin, the slow dissociation kinetics 433 
we observed suggest that the PGA-LPS interaction is not weak (e.g. no immediate return of the 434 
SPR signal to baseline at 70-120 seconds in Fig. 5A and B). These results indicate that the SPR 435 
binding detected between LPS and PGA is specific (i.e. not resulting from random electrostatic or 436 
hydrophobic interactions or the use of low, non-stringent, flow rates of 5 µL/min). Therefore, our 437 
current study provides the first direct evidence of a specific binding between PGA and LPS in A. 438 
pleuropneumoniae serotype 1.   439 
     Our subsequent evaluation of PGA production by immunoblotting demonstrated that the O-440 
antigen mutant 44.1 had less cell-associated PGA compared to the parental strain, the core mutant 441 
CG3, or the capsule mutant 33.2 (Fig. 6).  Complementary qRT-PCR analyses also revealed a 442 
down-regulation of the pgaA gene in the O-antigen mutant 44.1 (Fig. 7), thereby corroborating the 443 
defect in PGA production observed by immunoblotting.  This defect likely accounts for the 444 
inability of the O-antigen mutant to form robust biofilms. It is important to note that the O-antigen 445 
mutant 44.1 we used in this study has a transposon insertion in the rfbN gene which encodes a 446 
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rhamnosyl transferase involved in the assembly of the O chain (15). Recently, a rhamnosyl 447 
transferase (wxocB) mutant, resulting in a complete loss of the O chain in X. oryzae pv. Oryzicola, 448 
produced significantly less EPS (40).  449 
     Considering the critical position of LPS at cell-cell and cell-surface interfaces, we investigated 450 
the putative effect of the O-antigen truncation on the two-component regulatory system CpxRA. It 451 
is well established that CpxRA senses envelope stress, such as overproduction or misfolding of 452 
membrane molecules (37), and the Cpx system controls genes involved in biofilm formation of E. 453 
coli strains (38, 39). In several Gram-negative bacteria, Cpx envelope stress response is activated 454 
by pH, osmolarity, alterations in inner membrane composition, and surface adhesion (37). Indeed, 455 
Otto and Silhavy showed that the E. coli Cpx system was highly induced in mature biofilms (60). 456 
Using a cpxR mutant, Beloin and co-workers demonstrated that  E. coli K-12 was unable to 457 
produce mature biofilms; with only dispatched  microcolonies being observed by confocal 458 
microscopy (39). In addition, previous transcriptomic analyses from our group have demonstrated 459 
differential regulation of cpxR or cpxA when A. pleuropneumoniae grew as biofilms (27). In the 460 
present study, we now show that cpxA and cpxR expression in the O-antigen mutant 44.1 were 461 
significantly down-regulated compared to the LPS core mutant CG3, the capsule mutant 33.2, or 462 
the parental strain (Fig. 7). Therefore, it is conceivable that the absence of O-antigen results in the 463 
down-regulation of cpxRA. Knowing that both regulators sigma(E) (positive regulator) and H-NS 464 
(negative regulator) independently regulate the expression of the pga operon (25), further 465 
investigations will be required to determine how the Cpx system in A. pleuropneumoniae directly 466 
or indirectly affects the pgaABCD operon.  467 
     In conclusion, our current study provides important new insights about surface polysaccharides 468 
in A. pleuropneumoniae.  While truncation of the LPS core oligosaccharide or the absence of CPS 469 
did not have any effect, absence of PGA or O-antigen markedly reduced the ability of A. 470 
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pleuropneumoniae serotype 1 to form a mature biofilm. This finding was linked for the O-antigen 471 
mutant to a reduced pgaA expression and, consequently, reduced PGA production. Moreover, we 472 
have successfully demonstrated for the first time a direct binding interaction between LPS and 473 
PGA in A. pleuropneumoniae serotype 1, and this may represent a new strategy to prevent biofilm 474 
formation. However, our study demonstrated that the absence of the LPS O-antigen did not abolish 475 
this binding interaction and the defect in A. pleuropneumoniae biofilm formation was associated 476 
with reduced expression and production of PGA. Interestingly, the O-antigen mutant also 477 
exhibited reduced cpxRA expression; the link between CpxRA system and biofilm formation in A. 478 
pleuropneumoniae warrants further investigation. 479 
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Figure 1. (A) Optical density of biofilm formation in 96-well microtiter plates by the A. 687 
pleuropneumoniae parental strain 4074NalR, O-antigen mutant 44.1, LPS-core mutant CG3, 688 
capsule mutant 33.2 and pgaC mutant. (B) Dry weight of 24h biofilms (average mg ± SD from 3 689 
independent experiments) formed on a glass slide in the drip flow reactor system by the A. 690 
pleuropneumoniae parental strain 4074NalR (11.6 ± 2.5 mg), the O-antigen mutant 44.1 (barely 691 
detectable), the LPS-core mutant CG3 (12.2 ± 4.6 mg), the capsule mutant 33.2 (14.9 ± 4.5 mg) 692 
and pgaC mutant (not detected). Statistical analysis was performed using ANOVA where 693 
*P<0.05 when compared to the parental strain 4074 NalR. 694 
 695 
Figure 2. CLSM images of biofilms formed in 96-well microtiter plates by the A. 696 
pleuropneumoniae parental strain 4074NalR (A), the O-antigen mutant 44.1 (B), the LPS-core 697 
mutant CG3 (C), and the capsule mutant 33.2 (D) stained with WGA-Oregon Green 488. The X-698 
Y planes of the biofilms are shown in the upper row and the 3D images are shown in the bottom 699 
row (insert numerical values represent the biomass (µm3/µm2) of each biofilm). 700 
 701 
Figure 3. CLSM images of biofilms formed in 96-well microtiter plates by the A. 702 
pleuropneumoniae parental strain 4074 and the pgaC mutant stained FilmTracer™ FM®1-43, a 703 
fluorescent probe that stains bacterial membranes. The 3D images were obtained by using the 704 
Fluoview software.   705 
 706 
Figure 4. Dispersion of biofilms formed in 96-well microtiter plates by A. pleuropneumoniae 707 
parental strain (4074NalR), the LPS-core mutant CG3, and the capsule mutant 33.2 by DNase I, 708 
proteinase K, and dispersin B (DspB). The means (± SD) of 3 independent experiments are 709 
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shown. Statistical analysis was performed using ANOVA. *P<0.05 when compared to the control 710 
(Ctr). 711 
 712 
Figure 5. Specific, dose-dependent binding between PGA and parental strain LPS or LPS from 713 
O-antigen mutant 44.1, as assessed by SPR using HPA sensors. (A) screening of BSA (dashed 714 
line, 0.1 mg/mL = 1 µM; 66 kDa), partental LPS (black line, 1 mg/mL; 1 µM if MW = 1000 715 
kDa), and LPS mutant 44.1 (grey line, 1 mg/mL; 1 µM if MW = 1000 kDa) binding to 716 
immobilized PGA (1400 RU; in-line reference subtraction = 1400 RU glucocerebrosides) at 25 717 
µL/min in HBS running buffer; (B) screening of solution-phase PGA (1 mg/mL) binding to 718 
immobilized parental strain LPS and LPS of mutant 44.1 (1000 RU each, black and grey lines, 719 
respectively; in-line reference subtraction = 1000 RU immobilized PGA) at 25 µL /min in PBS 720 
running buffer; (C) single-cycle titrations of parental strain LPS and mutant 44.1 LPS (0.0313, 721 
0.0625, 0.125, 0.25, 0.5 mg/mL; black and grey lines, respectively) binding to immobilized PGA 722 
(1000 RU; in-line reference subtraction = 1000 RU BSA) at 25 µL/min in PBS running buffer. 723 
 724 
Figure 6. Detection of PGA in the biofilm matrix isolated from the parental strain 4074NalR and 725 
mutant strains cultured in a drip flow reactor for 24 h. Starting wells (1/1) contained 75µg  and 726 
then were serially diluted (1/2 to 1/512).  727 
 728 
Figure 7.  Relative expression of pgaA (A), cpxA and cpxR (B) of  the O-antigen mutant 44.1, the 729 
LPS-core mutant CG3, and the capsule mutant 33.2  compared to the parental strain 4074NalR. 730 
The means ± SD from 3 independent experiments are shown. Statistical analysis were performed 731 
using 2-ΔΔCt values and all results with (*) were statistically significant (P<0.05).  732 
 733 
 34 
 
Table 1.  Actinobacillus pleuropneumoniae strains used in the present study. 734 
Strains Relevant traits Affected 
gene 
Putative gene function Reference
4074Nalr Serotype 1 (Nalr)a, 
parent strain 
 
  (15) 
44.1 b LPS O-antigen 
mutant 
 
rfbN rhamnosyltransferase (15) 
CG3 b LPS core 
oligosaccharide 
mutant; still 
expressing a 
complete O-antigen
lbgB D-glycero-D-manno-
heptosyl transferase 
(9) 
33.2 b Acapsular mutant 
 
cpxC capsule polysaccharide 
export inner-membrane 
protein 
(13) 
ΔpgaC c Exopolysaccharide 
PGA mutant 
 
pgaC Integral membrane 
glycoside transferase 
enzyme 
(25) 
a Nalidixic acid-resistant, Nalr  735 
b Derived from A. pleuropneumoniae serotype 1 4074Nalr 736 
c  Derived from A. pleuropneumoniae serotype 1 4074  737 
 35 
 
Table 2. Primers used for quantitative real-time reverse-transcriptase (RT)-PCR. 738 
 739 
Primer Sequence Fragment size (bp) 
16SrRNA_Fw GGAATAACTGGGCGTAAAGG 200 
16SrRNA_Dw GCTCAGTACATTCCCAAGG 
pgaA_Fw GATAAAGCAAGCCAGTTCTTAGGT 215 
pgaA_Dw GCTGTTTGATGAGAAATACCGA 
cpxR_Fw TTGATGTTAAGCGCCAGAGA 185 
cpxR_Dw CCGGAGACTGGTTGGAATAA 
cpxA_Fw CGGATATTTCGCATGAACTG 187 
cpxA_Dw GCGGGTCAAATGCTGATTG 
dspB_Fw CATTCAAGCCGGCATTTC 216 
dspB_Dw TTGAGCGTCACCGTCGTA 
 740 
 741 
 742 
 743 







